SCD1 deficiency protects mice against ethanol-induced liver injury

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1861, Issue 11, 2016, Pages 1662-1670

  Lounis, Mohamed A ^a   Escoula, Quentin ^a   Veillette, Cathy ^a   Bergeron, Karl F ^a   Ntambi, James M ^b   Mounier, Catherine ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Alcoholic fatty liver disease; De novo lipogenesis; Inflammation; SCD1

Indexed keywords

ACYL COENZYME A DESATURASE 1; ALCOHOL; RNA; TRIACYLGLYCEROL; ACYL COENZYME A DESATURASE; FATTY ACID; PROTECTIVE AGENT; SCD1 PROTEIN, MOUSE;

ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXPERIMENTAL FATTY LIVER; FEEDING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIPOGENESIS; LIVER PROTECTION; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BODY COMPOSITION; C57BL MOUSE; COMPLICATION; DEFICIENCY; DIET; ENZYMOLOGY; FEEDING BEHAVIOR; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; INFLAMMATION; INJURIES; KNOCKOUT MOUSE; LIVER; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

ANIMALS; BODY COMPOSITION; DIET; ETHANOL; FATTY ACIDS; FATTY LIVER, ALCOHOLIC; FEEDING BEHAVIOR; GENE DELETION; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INFLAMMATION; LIPOGENESIS; LIVER; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PROTECTIVE AGENTS; STEAROYL-COA DESATURASE;

EID: 84981268262     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.07.012     Document Type: Article

References (43)

1. [1] Williams, J.A., Manley, S., Ding, W.X., New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J. Gastroenterol. 20:36 (2014), 12908–12933.
2. [2] O'Shea, R.S., Dasarathy, S., McCullough, A.J., Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G, Alcoholic liver disease. Hepatology 51:1 (2010), 307–328.
3. [3] Lucey, M.R., Mathurin, P., Morgan, T.R., Alcoholic hepatitis. N. Engl. J. Med. 360:26 (2009), 2758–2769.
4. [4] Liu, J., Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J. Gastroenterol. 20:40 (2014), 14672–14685.
5. [5] Levene, A.P., Goldin, R.D., The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 61:2 (2012), 141–152.
6. [6] Mendenhall, C.L., Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am. J. Dig. Dis. 13:9 (1968), 783–791.
7. [7] Teli, M.R., Day, C.P., Burt, A.D., Bennett, M.K., James OF, Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346:8981 (1995), 987–990.
8. [8] Sorensen, T.I., Orholm, M., Bentsen, K.D., Hoybye, G., Eghoje, K., Christoffersen, P., Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2:8397 (1984), 241–244.
9. [9] Mello, T., Ceni, E., Surrenti, C., Galli, A., Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol. Asp. Med. 29:1–2 (2008), 17–21.
10. [10] Israel, Y., Kalant, H., Khanna, J.M., Orrego, H., Phillips, M.J., Stewart, D.J., Ethanol metabolism, oxygen availability and alcohol induced liver damage. Adv. Exp. Med. Biol. 85A (1977), 343–358.
11. [11] Louvet, A., Mathurin, P., Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat. Rev. Gastroenterol. Hepatol. 12:4 (2015), 231–242.
12. [12] You, M., Fischer, M., Deeg, M.A., Crabb, D.W., Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277:32 (2002), 29342–29347.
13. [13] Strable, M.S., Ntambi, J.M., Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit. Rev. Biochem. Mol. Biol. 45:3 (2010), 199–214.
14. [14] Yamashita, H., Kaneyuki, T., Tagawa, K., Production of acetate in the liver and its utilization in peripheral tissues. Biochim. Biophys. Acta 1532:1–2 (2001), 79–87.
15. [15] Tilg, H., Diehl, A.M., Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343:20 (2000), 1467–1476.
16. [16] Cohen, P., Miyazaki, M., Socci, N.D., Hagge-Greenberg, A., Liedtke, W., Soukas, A.A., et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:5579 (2002), 240–243.
17. [17] Bjermo, H., Riserus, U., Role of hepatic desaturases in obesity-related metabolic disorders. Curr. Opin. Clin. Nutr. Metab. Care 13:6 (2010), 703–708.
18. [18] Ntambi, J.M., Miyazaki, M., Stoehr, J.P., Lan, H., Kendziorski, C.M., Yandell, B.S., et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. U. S. A. 99:17 (2002), 11482–11486.
19. [19] MacDonald, M.L., Singaraja, R.R., Bissada, N., Ruddle, P., Watts, R., Karasinska, J.M., et al. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. J. Lipid Res. 49:1 (2008), 217–229.
20. [20] Bertola, A., Mathews, S., Ki, S.H., Wang, H., Gao, B., Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat. Protoc. 8:3 (2013), 627–637.
21. [21] Ki, S.H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J.K., Bataller, R., et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52:4 (2010), 1291–1300.
22. [22] Berlanga, A., Guiu-Jurado, E., Porras, J.A., Auguet, T., Molecular pathways in non-alcoholic fatty liver disease. Clin. Exp. Gastroenterol. 7 (2014), 221–239.
23. [23] Gao, B., Bataller, R., Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:5 (2011), 1572–1585.
24. [24] You, M., Matsumoto, M., Pacold, C.M., Cho, W.K., Crabb, D.W., The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127:6 (2004), 1798–1808.
25. [25] Kim, E., Lee, J.H., Ntambi, J.M., Hyun, C.K., Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro. Eur. J. Pharmacol. 672:1–3 (2011), 38–44.
26. [26] Miyazaki, M., Dobrzyn, A., Man, W.C., Chu, K., Sampath, H., Kim, H.J., et al. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J. Biol. Chem. 279:24 (2004), 25164–25171.
27. [27] Miyazaki, M., Flowers, M.T., Sampath, H., Chu, K., Otzelberger, C., Liu, X., et al. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 6:6 (2007), 484–496.
28. [28] Rao, G.A., Lew, G., Larkin, E.C., Alcohol ingestion and levels of hepatic fatty acid synthetase and stearoyl-CoA desaturase activities in rats. Lipids 19:2 (1984), 151–153.
29. [29] Nakamura, M.T., Tang, A.B., Villanueva, J., Halsted, C.H., Phinney, S.D., Selective reduction of delta 6 and delta 5 desaturase activities but not delta 9 desaturase in micropigs chronically fed ethanol. J. Clin. Invest. 93:1 (1994), 450–454.
30. [30] Pawlosky, R.J., Salem, N. Jr., Perspectives on alcohol consumption: liver polyunsaturated fatty acids and essential fatty acid metabolism. Alcohol 34:1 (2004), 27–33.
31. [31] Retterstol, K., Lund, A.M., Tverdal, S., Cristophersen, B.O., Metabolism of some radiolabeled essential fatty acids in isolated rat hepatocytes is affected by dietary ethanol. Alcohol 21:1 (2000), 19–26.
32. [32] Petersson, H., Arnlov, J., Zethelius, B., Riserus, U., Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men. Diabetes Res. Clin. Pract. 87:3 (2010), 379–384.
33. [33] Tai, E.S., bin Ali, A., Zhang, Q., LM, L., CE, T., Retnam, L., et al. Hepatic expression of PPARalpha, a molecular target of fibrates, is regulated during inflammation in a gender-specific manner. FEBS Lett. 546:2–3 (2003), 237–240.
34. [34] Liu, X., Strable, M.S., Ntambi, J.M., Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv. Nutr. 2:1 (2011), 15–22.
35. [35] Kirpich, I.A., Miller, M.E., Cave, M.C., Joshi-Barve, S., McClain, C.J., Alcoholic liver disease: update on the role of dietary fat. Biomolecules, 6(1), 2016.
36. [36] Nanji, A.A., Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34:1 (2004), 21–25.
37. [37] Ronis, M.J., Korourian, S., Zipperman, M., Hakkak, R., Badger, T.M., Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J. Nutr. 134:4 (2004), 904–912.
38. [38] Chen, P., Torralba, M., Tan, J., Embree, M., Zengler, K., Starkel, P., et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology 148:1 (2015), 203–214 e16.
39. [39] You, M., Cao, Q., Liang, X., Ajmo, J.M., Ness, G.C., Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice. J. Nutr. 138:3 (2008), 497–501.
40. [40] Rosqvist, F., Iggman, D., Kullberg, J., Cedernaes, J., Johansson, H.E., Larsson, A., et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 63:7 (2014), 2356–2368.
41. [41] Lieber, C.S., Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol. Clin. Exp. Res. 15:4 (1991), 573–592.
42. [42] Musso, G., Gambino, R., Cassader, M., Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48:1 (2009), 1–26.
43. [43] Koo, S.H., Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin. Mol. Hepatol. 19:3 (2013), 210–215.